Authors:
BRAIN E
SOULIE P
DELALANDE B
BERNARD A
BANAL A
MAHE E
CVITKOVIC F
ROUESSE J
RAMBERT P
Citation: E. Brain et al., INTENSIFIED ALTERNATING CHEMOTHERAPY (CT) AND RADIOTHERAPY (RT) FOR STAGE-III-IV HEAD-AND-NECK-CANCER (HNC) PATIENTS (PTS), Annals of oncology, 9, 1998, pp. 365-365
Authors:
KOOMANGERSMANN M
VOGELSANG R
VOSSEN P
VANDENHOOVEN HW
MAHE E
HONEE G
DEWIT PJGM
Citation: M. Koomangersmann et al., CORRELATION BETWEEN BINDING-AFFINITY AND NECROSIS-INDUCING ACTIVITY OF MUTANT AVR9 PEPTIDE ELICITORS, Plant physiology, 117(2), 1998, pp. 609-618
Citation: E. Mahe et V. Descamps, PUVA THERAPY AND HUMAN-PAPILLOMAVIRUS TYPE-5 DETECTION IN PSORIASIS, Journal of investigative dermatology, 111(5), 1998, pp. 912-913
Authors:
PHALIPOU S
COTTE N
CARNAZZI E
SEYER R
MAHE E
JARD S
BARBERIS C
MOUILLAC B
Citation: S. Phalipou et al., MAPPING PEPTIDE-BINDING DOMAINS OF THE HUMAN V1A VASOPRESSIN RECEPTORWITH A PHOTOACTIVATABLE LINEAR PEPTIDE ANTAGONIST, The Journal of biological chemistry, 272(42), 1997, pp. 26536-26544
Authors:
ALA Y
MORIN D
MAHE E
COTTE N
MOUILLAC B
JARD S
BARBERIS C
TRIBOLLET E
DREIFUSS JJ
SAWYER WH
WO NC
CHAN WY
KOLODZIEJCZYK AS
CHENG LL
MANNING M
Citation: Y. Ala et al., PROPERTIES OF A NEW RADIOIODINATED ANTAGONIST FOR HUMAN VASOPRESSIN V-2 AND V-1A RECEPTORS, European journal of pharmacology, 331(2-3), 1997, pp. 285-293
Authors:
MCINTOSH JM
YOSHIKAMI D
MAHE E
NIELSEN DB
RIVIER JE
GRAY WR
OLIVERA BM
Citation: Jm. Mcintosh et al., A NICOTINIC ACETYLCHOLINE-RECEPTOR LIGAND OF UNIQUE SPECIFICITY, ALPHA-CONOTOXIN-IMI, The Journal of biological chemistry, 269(24), 1994, pp. 16733-16739